BNP Paribas Financial Markets
SPPI

BNP Paribas Financial Markets’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

BNP Paribas Financial Markets’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-184
Closed -$177 – 4089
2023
Q2 		$177 Buy
184
+157
+581% +$155 ﹤0.01% 3833
2023
Q1 		$20 Sell
27
-2,777
-99% -$2.03K ﹤0.01% 3811
2022
Q4 		$1.03K Buy
2,804
+1,513
+117% +$638 ﹤0.01% 3799
2022
Q3 		$555 Sell
1,291
-30,361
-96% -$29.8K ﹤0.01% 4507
2022
Q2 		$24.7K Buy
31,652
+16,460
+108% +$14.5K ﹤0.01% 3675
2022
Q1 		$19.6K Sell
15,192
-58,799
-79% -$54.1K ﹤0.01% 3730
2021
Q4 		$94K Sell
73,991
-84,960
-53% -$152K ﹤0.01% 3610
2021
Q3 		$347K Buy
158,951
+100,995
+174% +$276K ﹤0.01% 2882
2021
Q2 		$217K Sell
57,956
-36,665
-39% -$127K ﹤0.01% 2848
2021
Q1 		$308K Sell
94,621
-156,040
-62% -$559K ﹤0.01% 2838
2020
Q4 		$855K Buy
250,661
+213,981
+583% +$881K ﹤0.01% 2123
2020
Q3 		$150K Buy
36,680
+20,585
+128% +$78.3K ﹤0.01% 2896
2020
Q2 		$54.4K Sell
16,095
-48,998
-75% -$143K ﹤0.01% 2999
2020
Q1 		$152K Buy
65,093
+33,375
+105% +$91.4K ﹤0.01% 3000
2019
Q4 		$115K Buy
31,718
+12,986
+69% +$105K ﹤0.01% 3223
2019
Q3 		$155K Buy
18,732
+5,292
+39% +$42.8K ﹤0.01% 2884
2019
Q2 		$116K Sell
13,440
-9,675
-42% -$86.5K ﹤0.01% 2951
2019
Q1 		$247K Buy
23,115
+20,954
+970% +$224K ﹤0.01% 2573
2018
Q4 		$18.9K Sell
2,161
-3,371
-61% -$42.9K ﹤0.01% 3128
2018
Q3 		$92.9K Buy
5,532
+454
+9% +$9.82K ﹤0.01% 2778
2018
Q2 		$106K Sell
5,078
-118,552
-96% -$2.2M ﹤0.01% 2758
2018
Q1 		$1.99M Buy
123,630
+87,181
+239% +$1.73M ﹤0.01% 1391
2017
Q4 		$691K Sell
36,449
-3,521
-9% -$63.8K ﹤0.01% 2241
2017
Q3 		$562K Buy
39,970
+18,623
+87% +$168K ﹤0.01% 1923
2017
Q2 		$159K Buy
21,347
+9,960
+87% +$65.1K ﹤0.01% 2579
2017
Q1 		$74K Sell
11,387
-1,378
-11% -$7.71K ﹤0.01% 2603
2016
Q4 		$56.5K Buy
12,765
+1,526
+14% +$6.4K ﹤0.01% 2766
2016
Q3 		$52.5K Sell
11,239
-7,879
-41% -$46.7K ﹤0.01% 2416
2016
Q2 		$126K Buy
19,118
+10,527
+123% +$74.4K ﹤0.01% 2047
2016
Q1 		$54.6K Sell
8,591
-6,695
-44% -$34.4K ﹤0.01% 1975
2015
Q4 		$92.2K Buy
15,286
+1,142
+8% +$6.53K ﹤0.01% 2386
2015
Q3 		$84.6K Buy
14,144
+8,569
+154% +$59.5K ﹤0.01% 2495
2015
Q2 		$38.1K Buy
5,575
+4,034
+262% +$25.6K ﹤0.01% 2651
2015
Q1 		$9.35K Buy
1,541
+1,540
+154,000% +$10.2K ﹤0.01% 2794
2014
Q4 		$7 Sell
1
-3,991
-100% -$29.3K ﹤0.01% 1968
2014
Q3 		$32.5K Buy
3,992
+3,266
+450% +$25.6K ﹤0.01% 2849
2014
Q2 		$5.9K Buy
726
+380
+110% +$2.88K ﹤0.01% 2509
2014
Q1 		$2.38K Sell
346
-675
-66% -$5.71K ﹤0.01% 2603
2013
Q4 		$9.04K Sell
1,021
-16,100
-94% -$144K ﹤0.01% 2708
2013
Q3 		$143K Sell
17,121
-5,085
-23% -$41.2K ﹤0.01% 2339
2013
Q2 		$166K Buy
+22,206
New +$170K ﹤0.01% 2407

BNP Paribas Financial Markets's SPPI Position: Q3 2023 in Review

BNP Paribas Financial Markets sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 184 shares — an estimated $177 sold.

BNP Paribas Financial Markets first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $1.99M in Q1 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • BNP Paribas Financial Markets reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 184 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $177.
  • BNP Paribas Financial Markets first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
  • BNP Paribas Financial Markets's Spectrum Pharmaceuticals Inc position peaked at $1.99M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.